Testing effectiveness (Phase 2)Ended earlyNCT01392170What this trial is testingPegasys in Patients With Chronic Myeloid Leukemia (CML)Who this might be right forLeukemia M.D. Anderson Cancer Center 2
Large-scale testing (Phase 3)Temporarily pausedNCT01755325What this trial is testingPhase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+Who this might be right forChronic Myelogenous Leukemia Junmin Li 680
Early research (Phase 1)Ended earlyNCT01751425What this trial is testingRuxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase InhibitorsWho this might be right forChronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Myelogenous Leukemia, BCR-ABL1 Positive in RemissionMinimal Residual Disease+1 more M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT01207440What this trial is testingPonatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)Who this might be right forChronic Myeloid LeukemiaPh+ Acute Lymphoblastic Leukemia Ariad Pharmaceuticals 449
Large-scale testing (Phase 3)Active Not RecruitingNCT05456191What this trial is testingInvestigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)Who this might be right forPhiladelphia Chromosome-Positive Chronic Myeloid Leukemia Novartis Pharmaceuticals 568
Testing effectiveness (Phase 2)Ended earlyNCT00644878What this trial is testingStudy of Molecular Response in Adult Patients on Nilotinib With Philadelphia Chromosome Positive Chronic Myelogenous Leukemia (Ph+ CML) in Chronic Phase and a Suboptimal Molecular Response to ImatinibWho this might be right forChronic Myelogenous Leukemia - Chronic Phase Novartis Pharmaceuticals 18
Testing effectiveness (Phase 2)Study completedNCT00171249What this trial is testingAn Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ LeukemiaWho this might be right forPhiladelphia Positive Chronic Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia Novartis Pharmaceuticals 293
Early research (Phase 1)Study completedNCT02081378What this trial is testingA Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALLWho this might be right forChronic Myelogenous LeukemiaPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia Novartis Pharmaceuticals 326
Testing effectiveness (Phase 2)Study completedNCT00171158What this trial is testingAn Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast CrisisWho this might be right forPhiladelphia Chromosome Positive CML Novartis Pharmaceuticals 260
Very early researchLooking for participantsNCT07074496What this trial is testingEfficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.Who this might be right forPhiladelphia Chromosome-Positive Acute Lymphoblastic Leukemia The First Affiliated Hospital of Soochow University 20
Large-scale testing (Phase 3)Looking for participantsNCT03459534What this trial is testingThe Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIsWho this might be right forChronic Myeloid Leukemia, Chronic PhaseCML, Chronic PhaseCML, Refractory+1 more Il-Yang Pharm. Co., Ltd. 173
Testing effectiveness (Phase 2)UnknownNCT03241199What this trial is testingThe Efficacy and Safety of Induction-Maintenance Protocol for Patients With Chronic Myelogenous LeukaemiaWho this might be right forChronic Myeloid LeukemiaPhiladelphia Chromosome Positive CML The University of Hong Kong 15
Early research (Phase 1)Ended earlyNCT00464113What this trial is testingStudy of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic LeukemiaWho this might be right forChronic Myeloid LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-Positive Exelixis 49
Testing effectiveness (Phase 2)Study completedNCT02997761What this trial is testingIbrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic LeukemiaWho this might be right forAdult B Acute Lymphoblastic LeukemiaPhiladelphia Chromosome Positive University of California, Davis 19
Not applicableUnknownNCT03709017What this trial is testingIclusig PMS in CML or Ph+ALL PatientsWho this might be right forChronic Myeloid LeukemiaPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia Korea Otsuka Pharmaceutical Co., Ltd. 50
Large-scale testing (Phase 3)Active Not RecruitingNCT03722420What this trial is testingRandomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)Who this might be right forChronic Myeloid Leukemia, Chronic Phase Il-Yang Pharm. Co., Ltd. 238
Not applicableStudy completedNCT04965649What this trial is testingIs There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance Mutations in Phi+ Hematological Malignancies.Who this might be right forLeukemiaMyelogenous LeukemiaChronic Leukemia+1 more Centre Hospitalier Universitaire de Nīmes 30
Early research (Phase 1)Ended earlyNCT02782403What this trial is testingAxitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia (CML)Blast Phase Chronic Myelogenous Leukemia (CML)Chronic Phase Phase Chronic Myelogenous Leukemia (CML)+1 more M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT02888990What this trial is testingDasatinib and Low Intensity Chemotherapy for Ph+ Acute Lymphoblastic LeukemiaWho this might be right forLeukemia, Lymphoblastic, Acute Versailles Hospital 71
Early research (Phase 1)Looking for participantsNCT07040982What this trial is testingAsciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaWho this might be right forB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 City of Hope Medical Center 30